The latest news from academia, regulators
research labs and other things of interest
Posted: July 25, 2008
GTCbio announces largest annual conference - the 4th Modern Drug Discovery and Development Summit
(Nanowerk News) GTCbio just announced the scheduling of one of the largest industry conferences taking place on October 15-17, 2008 in San Diego, CA. The 4th Modern Drug Discovery & Development features six full conferences, three symposia, six stand-alone sessions, and a plenary keynote session presenting some of the leaders in the field.
Now in its fourth year, the summit will once again provide a landscape and in-depth industry analysis streaming through different therapeutic and target areas, examining the current advancements and addressing the question that’s on everyone’s mind - where is the industry headed next?
The Summit’s six individual tracks will focus on biological therapeutics, translational medicine, drug design and lead discovery, emerging targets & therapeutics, pharmacokinetics & pharmacodynamics, and partnering, licensing & outsourcing. The three symposia taking place the first morning of the summit will feature presentations on stem cells as tools for drug discovery, imaging technologies, and regulatory updates in the industry.
Leading presenters from all over the world will come to San Diego on the 15th, 16th and 17th to discuss the outlook of the biopharmaceutical market place. Presenting organizations include, Pfizer, Merck, Novartis, Eli Lilly, GSK, Aventis, Genentech, Amgen, Biogen Idec, NIH, FDA and many more.
For more information on attending, presenting a poster, or sponsoring, please visit www.gtcbio.com.
GTCbio organizes conferences specifically for the biomedical and biopharmaceutical industries. Our goal is to facilitate the exchange of biopharmaceutical and biomedical intelligence between industry leaders, academic and government organizations, and the financial community.
GTCbio is a subsidiary of Global Technology Community, LLC, a privately held company founded in 2002.